The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice
Open accessAbstract
Alzheimer’s disease (AD) is the most common senile dementia in the world. Although important progress has been made in understanding the pathogenesis of AD, current therapeutic approaches provide only modest symptomatic relief. In this study, we evaluated the neuroprotective effect of quercetin (25 mg/kg) administration via i.p. injection every 48 hours for 3 months on aged (21–24 months old) triple transgenic AD model (3xTg-AD) mice. Our data show that quercetin decreases extracellular β-amyloidosis, tauopathy, astrogliosis and microgliosis in the hippocampus and the amygdala. These results were supported by a significant reduction in the paired helical filament (PHF), β-amyloid (βA) 1–40 and βA 1–42 levels and a decrease in BACE1-mediated cleavage of APP (into CTFβ). Additionally, quercetin induced improved performance on learning and spatial memory tasks and greater risk assessment behavior based on the elevated plus maze test. Together, these findings suggest that quercetin reverses histological hallmarks of AD and protects cognitive and emotional function in aged 3xTg-AD mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
The mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Walf, A. A., & Frye, C. A. (2007) · Nature Protocols · doi:10.1038/nprot.2007.44 · Cited by 3,035
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
The open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037//0033-2909.83.3.482 · Cited by 2,506
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
LeDoux, J. (2007) · Current Biology · doi:10.1016/j.cub.2007.08.005 · Cited by 1,281
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · cited 5×
“Animals Homozygous 3xTg-AD and non-transgenic (Non Tg) mice (Oddo et al., 2003b) from the inhouse colony at the University of Antioquia maintained at the SIU (Sede de Investigación Universitaria) specific pathogen-free vivarium in Medellin, Colombia, were used at 18–21 months old to obtain…”
BackgroundMethodInfluentialThe flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
ALZHEIMER'S DISEASE INTERNATIONAL
GRAHAM, N., & BRODATY, H. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199707)12:7<691::aid-gps648>3.0.co;2-f · Cited by 634
García-Mediavilla, V., Crespo, I., Collado, P. S., Esteller, A., Sánchez-Campos, S., Tuñón, M. J., & González-Gallego, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.014 · Cited by 563
Khan, U. A., Liu, L., Provenzano, F. A., Berman, D. E., Profaci, C. P., Sloan, R., Mayeux, R., Duff, K. E., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3606 · Cited by 561
Hutchinson, E. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2985 · Cited by 532
Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Shytle, R. D., & Tan, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.107 · Cited by 459
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's disease
Ansari, M. A., Abdul, H. M., Joshi, G., Opii, W. O., & Butterfield, D. A. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.03.002 · Cited by 420
Kleemann, R., Verschuren, L., Morrison, M., Zadelaar, S., van Erk, M. J., Wielinga, P. Y., & Kooistra, T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.023 · Cited by 401
Youdim, K. A., Shukitt-Hale, B., & Joseph, J. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.002 · Cited by 373
Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
Park, C. H., Chang, J. Y., Hahm, E. R., Park, S., Kim, H.-K., & Yang, C. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.151 · Cited by 337
Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., Van Eldik, L. J., & Norris, C. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-12.2012 · Cited by 313
Wang, J., Ho, L., Zhao, Z., Seror, I., Humala, N., Dickstein, D. L., Thiyagarajan, M., Percival, S. S., Talcott, S. T., & Maria Pasinetti, G. (2006) · The FASEB Journal · doi:10.1096/fj.06-6281com · Cited by 298
Devi, L., & Ohno, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.191 · Cited by 282
Janelsins, M. C., Mastrangelo, M. A., Oddo, S., LaFerla, F. M., Federoff, H. J., & Bowers, W. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-23 · Cited by 260
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
Iqbal, K., & Grundke‐Iqbal, I. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00225.x · Cited by 238
Mastrangelo, M. A., & Bowers, W. J. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-81 · Cited by 233
Giménez-Llort, L., Blázquez, G., Cañete, T., Johansson, B., Oddo, S., Tobeña, A., LaFerla, F. M., & Fernández-Teruel, A. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.007 · Cited by 231
Sterniczuk, R., Antle, M. C., LaFerla, F. M., & Dyck, R. H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.011 · Cited by 228 · cited 1×
“…3xTg-AD mice exhibited reduced anxiety or a “risk assessment” behavior when they visit the open arms of the maze (Walf and Frye, 2007) compared to the vehicle-treated 3xTg-AD mice, which may exhibit a higher level of anxiety than control mice (GimenezLlort et al., 2007; Sterniczuk et al., 2010).”
BackgroundAnxiety and cognitive effects of quercetin liposomes in rats
Priprem, A., Watanatorn, J., Sutthiparinyanont, S., Phachonpai, W., & Muchimapura, S. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.12.001 · Cited by 221
The impact of flavonoids on memory: physiological and molecular considerations
Spencer, J. P. E. (2009) · Chemical Society Reviews · doi:10.1039/b800422f · Cited by 217
Ho, L., Ferruzzi, M. G., Janle, E. M., Wang, J., Gong, B., Chen, T., Lobo, J., Cooper, B., Wu, Q. L., Talcott, S. T., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-212118 · Cited by 204
Sharma, V., Mishra, M., Ghosh, S., Tewari, R., Basu, A., Seth, P., & Sen, E. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.01.016 · Cited by 202
Cardona-Gomez, P., Perez, M., Avila, J., Garcia-Segura, L. M., & Wandosell, F. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.008 · Cited by 197
Wang, D.-M., Li, S.-Q., Wu, W.-L., Zhu, X.-Y., Wang, Y., & Yuan, H.-Y. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1343-x · Cited by 195
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice
Piedrahita, D., Hernández, I., López-Tobón, A., Fedorov, D., Obara, B., Manjunath, B. S., Boudreau, R. L., Davidson, B., LaFerla, F., Gallego-Gómez, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3637-10.2010 · Cited by 183
Self-citationYao, R.-Q., Qi, D.-S., Yu, H.-L., Liu, J., Yang, L.-H., & Wu, X.-X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0871-5 · Cited by 183
The multiple faces of quercetin in neuroprotection
Ossola, B., Kääriäinen, T. M., & Männistö, P. T. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903026944 · Cited by 175
Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
Venneti, S., Wiley, C. A., & Kofler, J. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9142-2 · Cited by 170
Fiorani, M., Guidarelli, A., Blasa, M., Azzolini, C., Candiracci, M., Piatti, E., & Cantoni, O. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.014 · Cited by 169
Quercetin: A Pleiotropic Kinase Inhibitor Against Cancer
Russo, G. L., Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Iannitti, R., & Palumbo, R. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_11 · Cited by 167
Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglyconein vivo
Terao, J., Murota, K., & Kawai, Y. (2011) · Food Funct. · doi:10.1039/c0fo00106f · Cited by 164
Tau Oligomers and Fibrils Induce Activation of Microglial Cells
Morales, I., Jiménez, J. M., Mancilla, M., & Maccioni, R. B. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-131843 · Cited by 160
Vissiennon, C., Nieber, K., Kelber, O., & Butterweck, V. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.017 · Cited by 160
Chakraborty, J., Singh, R. P., Dutta, D., Naskar, A., Rajamma, U., & Mohanakumar, K. P. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12189 · Cited by 156
Yamin, G. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21998 · Cited by 155
Li, F.-Q., Wang, T., Pei, Z., Liu, B., & Hong, J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0213-0 · Cited by 147
Martínez‐Flórez, S., Gutiérrez-Fernández, B., Sánchez‐Campos, S., González‐Gallego, J., & Tuñón, M. J. (2005) · Journal of Nutrition · doi:10.1093/jn/135.6.1359 · Cited by 143
Entorhinal Cortex Thickness Predicts Cognitive Decline in Alzheimer's Disease
Velayudhan, L., Proitsi, P., Westman, E., Muehlboeck, J., Mecocci, P., Vellas, B. J., Tsolaki, M., Kłoszewska, I., Soininen, H. S., Spenger, C., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121408 · Cited by 140
Patil, C. S., Singh, V. P., Satyanarayan, P. S. V., Jain, N., Singh, À., & Kulkarni, S. K. (2003) · Pharmacology · doi:10.1159/000072357 · Cited by 135
Pérez‐Vizcaíno, F., Duarte, J., & Santos‐Buelga, C. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5697 · Cited by 135
Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
Gong, E. J., Park, H. R., Kim, M. E., Piao, S., Lee, E., Jo, D., Chung, H. Y., Ha, N., Mattson, M. P., & Lee, J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.005 · Cited by 129
Lavoie, S., Chen, Y., Dalton, T. P., Gysin, R., Cuénod, M., Steullet, P., & Kim, Q. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05908.x · Cited by 127
Psahoulia, F. H., Moumtzi, S. S., Roberts, M. L., Sasazuki, T., Shirasawa, S., & Pintzas, A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl232 · Cited by 125
Chimenti, F., Cottiglia, F., Bonsignore, L., Casu, L., Casu, M., Floris, C., Secci, D., Bolasco, A., Chimenti, P., Granese, A., et al. (2006) · Journal of Natural Products · doi:10.1021/np060015w · Cited by 124
George, R. C., Lew, J., & Graves, D. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122113 · Cited by 123
Abdalla, F. H., Schmatz, R., Cardoso, A. M., Carvalho, F. B., Baldissarelli, J., de Oliveira, J. S., da Rosa, M. M., Nunes, M. A. G., Rubin, M. A., da Cruz, I. B. M., et al. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.06.008 · Cited by 122
Banerjee, T., van der Vliet, A., & Ziboh, V. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0387 · Cited by 117
Side effects of approved antidementives.
Mimica, N., & Presečki, P. (2009) · PubMed · Cited by 114
Merzoug, S., Toumi, M. L., & Tahraoui, A. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1008-y · Cited by 110
Choi, S., Kim, B. C., Cho, Y.-H., Choi, K., Chang, J. Y., Park, M., Kim, M., Cho, K.-H., & Kim, J.-K. (2014) · Chonnam Medical Journal · doi:10.4068/cmj.2014.50.2.45 · Cited by 105
DuPont, M. S., O’Leary, K. A., Needs, P. W., Bao, Y., de Pascual‐Teresa, S., Johnston, K. L., Morgan, L., Clifford, M. N., & Williamson, G. (2004) · Journal of Nutrition · doi:10.1093/jn/134.3.552 · Cited by 105
Genistein protects dopaminergic neurons by inhibiting microglial activation
Wang, X., Chen, S., Ma, G., Ye, M., & Lü, G. (2005) · Neuroreport · doi:10.1097/00001756-200502280-00013 · Cited by 99
Yao, H., Liu, Y., Zhou, B., Zhang, Z., An, N., Wang, P., Wang, L., Zhang, X., & Jiang, T. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.03.019 · Cited by 97
Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs Disease
Bassil, N., & Grossberg, G. T. (2009) · CNS Drugs · doi:10.2165/00023210-200923040-00003 · Cited by 93
Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine
Mancuso, C., Siciliano, R., Barone, E., & Preziosi, P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.004 · Cited by 91
Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42.
Bate, C., Salmona, M., & Williams, A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-4 · Cited by 88
Parachikova, A., Green, K. N., Hendrix, C., & LaFerla, F. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014015 · Cited by 87
Cao, X., Liu, M., Tuo, J., Shen, D., & Chan, C. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.016 · Cited by 83
Ksiȩżak-Reding, H., Ho, L., Santa‐María, I., Díaz-Ruiz, C., Wang, J., & Pasinetti, G. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.006 · Cited by 78
Yao, Y., Han, D. D., Zhang, T., & Yang, Z. R. (2009) · Phytotherapy Research · doi:10.1002/ptr.2902 · Cited by 76
Kanter, M., Ünsal, C., Aktaş, C., & Erboğa, M. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713504810 · Cited by 73
Proatherogenic Macrophage Activities Are Targeted by the Flavonoid Quercetin
Lara-Guzmán, O. J., Tabares-Guevara, J. H., León-Varela, Y. M., Álvarez, R., Roldán, M., Sierra, J. A., Londoño‐Londoño, J., & Ramírez‐Pineda, J. R. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196147 · Cited by 72
Self-citationMicroglia in Alzheimer Brain: A Neuropathological Perspective
Mrak, R. E. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/165021 · Cited by 71
The Natural Flavonoid Quercetin Ameliorates Cerulein-Induced Acute Pancreatitis in Mice
Carvalho, K. M. M. B., Morais, T. C., de Melo, T. S., Brito, G. A. D. C., de Andrade, G. M., Rao, V. S. N., & Santos, F. A. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1534 · Cited by 69
Liu, R., Zhang, T., Zhou, D., Bai, X., Zhou, W., Huang, C., Song, J.-K., Meng, F.-R., Wu, C., Li, L., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.018 · Cited by 59
Lee, D. C., Rizer, J., Hunt, J. B., Selenica, M. ‐. B., Gordon, M. N., & Morgan, D. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12002 · Cited by 57
An update on treatment and prevention strategies for Alzheimer’s disease
Neugroschl, J. A., & Sano, M. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0054-1 · Cited by 56
Jia, N., Han, K. S., Kong, J., Zhang, X., Sha, S., Ren, G.-R., & Cao, Y. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1675-x · Cited by 55
Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease
Thangavel, R., Stolmeier, D. A., Yang, X., Anantharam, P., & Zaheer, A. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01232.x · Cited by 54
Quercetin Protects Mouse Brain against Lead-Induced Neurotoxicity
Liu, C., Zheng, G., Cheng, C., & Sun, J.-M. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf303387d · Cited by 48
Kääriäinen, T. M., Piltonen, M., Ossola, B., Kekki, H., Lehtonen, Š., Nenonen, T., Lecklin, A., Raasmaja, A., & Männistö, P. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.089 · Cited by 46
Effects of Natural Flavones and Flavonols on the Kinase Activity of Cdk5
Zapata‐Torres, G., Opazo, F., Salgado, J. C., Muñoz, J. P., Krautwurst, H., Mascayano, C., Sepúlveda‐Boza, S., Maccioni, R. B., & Cassels, B. K. (2004) · Journal of Natural Products · doi:10.1021/np034011s · Cited by 44
Karim, N., Gavande, N. S., Wellendorph, P., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.002 · Cited by 43
Rodriguez, J. J., Noristani, H. N., Hilditch, T., Olabarria, M., Yeh, C., Witton, J., & Verkhratsky, A. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.036 · Cited by 40
Castro-Álvarez, J. F., Uribe‐Arias, A., Kosik, K. S., & Cardona‐Gómez, G. P. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00243 · Cited by 40
Self-citationBoonpawa, R., Spenkelink, A., Rietjens, I. M. C. M., & Punt, A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.007 · Cited by 21
Cur(Que)min: A neuroactive permutation of Curcumin and Quercetin for treating spinal cord injury
Kumar, P., Choonara, Y. E., Modi, G., Naidoo, D., & Pillay, V. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.01.019 · Cited by 16
Miyai, S., Yamaguchi, A., Iwasaki, T., Shamsa, F., & Ohtsuki, K. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1932 · Cited by 12
Cited by
Batiha, G. E.-S., Beshbishy, A. M., Ikram, M., Mulla, Z. S., El-Hack, M. E. A., Taha, A. E., Algammal, A. M., & Elewa, Y. H. A. (2020) · Foods · doi:10.3390/foods9030374 · Cited by 709
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
Salehi, B., Machin, L., Monzote, L., Sharifi-Rad, J., Ezzat, S. M., Salem, M. A., Merghany, R. M., El Mahdy, N. M., Kılıç, C. S., Sytar, O., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01818 · Cited by 707
Recent Advances in Potential Health Benefits of Quercetin
Aghababaei, F., & Hadidi, M. (2023) · Pharmaceuticals · doi:10.3390/ph16071020 · Cited by 616
Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Khan, H., Ullah, H., Aschner, M., Cheang, W. S., & Akkol, E. K. (2019) · Biomolecules · doi:10.3390/biom10010059 · Cited by 537
Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases
Forni, C., Facchiano, F., Bartoli, M., Pieretti, S., Facchiano, A., D’Arcangelo, D., Norelli, S., Valle, G., Nisini, R., Beninati, S., et al. (2019) · BioMed Research International · doi:10.1155/2019/8748253 · Cited by 513
Metadata
- Authors
- Sabogal-Guáqueta, A. M., Muñoz-Manco, J. I., Ramírez-Pineda, J. R., Lamprea-Rodriguez, M., Osorio, E., & Cardona-Gómez, G. P.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 93
- Pages
- 134-145
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2039851764
- Cited by
- 447
- References
- 96
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.